JMP Securities Downgrades Franklin BSP Realty Trust to Market Perform
JMP Securities analyst Steven Delaney downgrades Franklin BSP Realty Trust (NYSE:FBRT) from Market Outperform to Market Perform.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
JonesTrading Initiates Coverage On Franklin BSP Realty Trust with Buy Rating, Announces Price Target of $17
JonesTrading analyst Jason Stewart initiates coverage on Franklin BSP Realty Trust (NYSE:FBRT) with a Buy rating and announces Price Target of $17.
JMP Securities Reinstates Market Outperform on Franklin BSP Realty Trust, Announces $15 Price Target
JMP Securities analyst Steven Delaney reinstates Franklin BSP Realty Trust (NYSE:FBRT) with a Market Outperform and announces $15 price target.
Franklin BSP Realty Trust Q4 EPS $0.36
Franklin BSP Realty Trust (NYSE:FBRT) reported quarterly earnings of $0.36 per share.
Franklin BSP Realty Trust Reports Closed $1.6B In Commitments For Q4’21
Franklin BSP Realty Trust, Inc. (NYSE:FBRT) (“FBRT” or the “Company”) today announced the Company closed a record $1.6 billion of commitments in the fourth quarter of 2021, resulting in record